Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: QYResearch | PRODUCT CODE: 1388686

Cover Image

PUBLISHER: QYResearch | PRODUCT CODE: 1388686

Global NAD+ Enhancer Market Insights, Forecast to 2029

PUBLISHED:
PAGES: 128 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4900
PDF (Multi User License)
USD 7350
PDF (Enterprise User License)
USD 9800

Add to Cart

This research report focuses on the NAD+ Enhancer Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 NAD+ Enhancer Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global NAD+ Enhancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Capsules
    • 1.2.3 Arm Transdermal Patch
    • 1.2.4 Infusion Fluids
    • 1.2.5 Nasal Spray
    • 1.2.6 Sublingual Tablets
    • 1.2.7 Other
  • 1.3 Market by Application
    • 1.3.1 Global NAD+ Enhancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Research Institutes
    • 1.3.5 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global NAD+ Enhancer Sales Estimates and Forecasts 2018-2029
  • 2.2 Global NAD+ Enhancer Revenue by Region
    • 2.2.1 Global NAD+ Enhancer Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global NAD+ Enhancer Revenue by Region (2018-2023)
    • 2.2.3 Global NAD+ Enhancer Revenue by Region (2024-2029)
    • 2.2.4 Global NAD+ Enhancer Revenue Market Share by Region (2018-2029)
  • 2.3 Global NAD+ Enhancer Sales Estimates and Forecasts 2018-2029
  • 2.4 Global NAD+ Enhancer Sales by Region
    • 2.4.1 Global NAD+ Enhancer Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global NAD+ Enhancer Sales by Region (2018-2023)
    • 2.4.3 Global NAD+ Enhancer Sales by Region (2024-2029)
    • 2.4.4 Global NAD+ Enhancer Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global NAD+ Enhancer Sales by Manufacturers
    • 3.1.1 Global NAD+ Enhancer Sales by Manufacturers (2018-2023)
    • 3.1.2 Global NAD+ Enhancer Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of NAD+ Enhancer in 2022
  • 3.2 Global NAD+ Enhancer Revenue by Manufacturers
    • 3.2.1 Global NAD+ Enhancer Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global NAD+ Enhancer Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by NAD+ Enhancer Revenue in 2022
  • 3.3 Global Key Players of NAD+ Enhancer, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global NAD+ Enhancer Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global NAD+ Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of NAD+ Enhancer, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of NAD+ Enhancer, Product Offered and Application
  • 3.8 Global Key Manufacturers of NAD+ Enhancer, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global NAD+ Enhancer Sales by Type
    • 4.1.1 Global NAD+ Enhancer Historical Sales by Type (2018-2023)
    • 4.1.2 Global NAD+ Enhancer Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • 4.2 Global NAD+ Enhancer Revenue by Type
    • 4.2.1 Global NAD+ Enhancer Historical Revenue by Type (2018-2023)
    • 4.2.2 Global NAD+ Enhancer Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • 4.3 Global NAD+ Enhancer Price by Type
    • 4.3.1 Global NAD+ Enhancer Price by Type (2018-2023)
    • 4.3.2 Global NAD+ Enhancer Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global NAD+ Enhancer Sales by Application
    • 5.1.1 Global NAD+ Enhancer Historical Sales by Application (2018-2023)
    • 5.1.2 Global NAD+ Enhancer Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • 5.2 Global NAD+ Enhancer Revenue by Application
    • 5.2.1 Global NAD+ Enhancer Historical Revenue by Application (2018-2023)
    • 5.2.2 Global NAD+ Enhancer Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • 5.3 Global NAD+ Enhancer Price by Application
    • 5.3.1 Global NAD+ Enhancer Price by Application (2018-2023)
    • 5.3.2 Global NAD+ Enhancer Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada NAD+ Enhancer Market Size by Type
    • 6.1.1 US & Canada NAD+ Enhancer Sales by Type (2018-2029)
    • 6.1.2 US & Canada NAD+ Enhancer Revenue by Type (2018-2029)
  • 6.2 US & Canada NAD+ Enhancer Market Size by Application
    • 6.2.1 US & Canada NAD+ Enhancer Sales by Application (2018-2029)
    • 6.2.2 US & Canada NAD+ Enhancer Revenue by Application (2018-2029)
  • 6.3 US & Canada NAD+ Enhancer Market Size by Country
    • 6.3.1 US & Canada NAD+ Enhancer Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada NAD+ Enhancer Sales by Country (2018-2029)
    • 6.3.3 US & Canada NAD+ Enhancer Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe NAD+ Enhancer Market Size by Type
    • 7.1.1 Europe NAD+ Enhancer Sales by Type (2018-2029)
    • 7.1.2 Europe NAD+ Enhancer Revenue by Type (2018-2029)
  • 7.2 Europe NAD+ Enhancer Market Size by Application
    • 7.2.1 Europe NAD+ Enhancer Sales by Application (2018-2029)
    • 7.2.2 Europe NAD+ Enhancer Revenue by Application (2018-2029)
  • 7.3 Europe NAD+ Enhancer Market Size by Country
    • 7.3.1 Europe NAD+ Enhancer Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe NAD+ Enhancer Sales by Country (2018-2029)
    • 7.3.3 Europe NAD+ Enhancer Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China NAD+ Enhancer Market Size
    • 8.1.1 China NAD+ Enhancer Sales (2018-2029)
    • 8.1.2 China NAD+ Enhancer Revenue (2018-2029)
  • 8.2 China NAD+ Enhancer Market Size by Application
    • 8.2.1 China NAD+ Enhancer Sales by Application (2018-2029)
    • 8.2.2 China NAD+ Enhancer Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia NAD+ Enhancer Market Size by Type
    • 9.1.1 Asia NAD+ Enhancer Sales by Type (2018-2029)
    • 9.1.2 Asia NAD+ Enhancer Revenue by Type (2018-2029)
  • 9.2 Asia NAD+ Enhancer Market Size by Application
    • 9.2.1 Asia NAD+ Enhancer Sales by Application (2018-2029)
    • 9.2.2 Asia NAD+ Enhancer Revenue by Application (2018-2029)
  • 9.3 Asia NAD+ Enhancer Sales by Region
    • 9.3.1 Asia NAD+ Enhancer Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia NAD+ Enhancer Revenue by Region (2018-2029)
    • 9.3.3 Asia NAD+ Enhancer Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America NAD+ Enhancer Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America NAD+ Enhancer Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America NAD+ Enhancer Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America NAD+ Enhancer Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America NAD+ Enhancer Sales by Country
    • 10.3.1 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America NAD+ Enhancer Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Chromadex
    • 11.1.1 Chromadex Company Information
    • 11.1.2 Chromadex Overview
    • 11.1.3 Chromadex NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Chromadex NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Chromadex Recent Developments
  • 11.2 Alive by Nature
    • 11.2.1 Alive by Nature Company Information
    • 11.2.2 Alive by Nature Overview
    • 11.2.3 Alive by Nature NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Alive by Nature NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Alive by Nature Recent Developments
  • 11.3 Life Extension
    • 11.3.1 Life Extension Company Information
    • 11.3.2 Life Extension Overview
    • 11.3.3 Life Extension NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Life Extension NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Life Extension Recent Developments
  • 11.4 Bulk Supplements
    • 11.4.1 Bulk Supplements Company Information
    • 11.4.2 Bulk Supplements Overview
    • 11.4.3 Bulk Supplements NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Bulk Supplements NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Bulk Supplements Recent Developments
  • 11.5 NMN Bio
    • 11.5.1 NMN Bio Company Information
    • 11.5.2 NMN Bio Overview
    • 11.5.3 NMN Bio NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 NMN Bio NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 NMN Bio Recent Developments
  • 11.6 Swanson Health
    • 11.6.1 Swanson Health Company Information
    • 11.6.2 Swanson Health Overview
    • 11.6.3 Swanson Health NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Swanson Health NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Swanson Health Recent Developments
  • 11.7 Pure Nootropics
    • 11.7.1 Pure Nootropics Company Information
    • 11.7.2 Pure Nootropics Overview
    • 11.7.3 Pure Nootropics NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Pure Nootropics NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Pure Nootropics Recent Developments
  • 11.8 Thrivous
    • 11.8.1 Thrivous Company Information
    • 11.8.2 Thrivous Overview
    • 11.8.3 Thrivous NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Thrivous NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Thrivous Recent Developments
  • 11.9 BioTech Life Sciences
    • 11.9.1 BioTech Life Sciences Company Information
    • 11.9.2 BioTech Life Sciences Overview
    • 11.9.3 BioTech Life Sciences NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 BioTech Life Sciences NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 BioTech Life Sciences Recent Developments
  • 11.10 Bioage
    • 11.10.1 Bioage Company Information
    • 11.10.2 Bioage Overview
    • 11.10.3 Bioage NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Bioage NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Bioage Recent Developments
  • 11.11 Alitura Naturals
    • 11.11.1 Alitura Naturals Company Information
    • 11.11.2 Alitura Naturals Overview
    • 11.11.3 Alitura Naturals NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 Alitura Naturals NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Alitura Naturals Recent Developments
  • 11.12 Genex Formulas
    • 11.12.1 Genex Formulas Company Information
    • 11.12.2 Genex Formulas Overview
    • 11.12.3 Genex Formulas NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 Genex Formulas NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Genex Formulas Recent Developments
  • 11.13 Prohealth
    • 11.13.1 Prohealth Company Information
    • 11.13.2 Prohealth Overview
    • 11.13.3 Prohealth NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.13.4 Prohealth NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Prohealth Recent Developments
  • 11.14 LifeSeasons
    • 11.14.1 LifeSeasons Company Information
    • 11.14.2 LifeSeasons Overview
    • 11.14.3 LifeSeasons NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.14.4 LifeSeasons NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 LifeSeasons Recent Developments
  • 11.15 Renue By Science
    • 11.15.1 Renue By Science Company Information
    • 11.15.2 Renue By Science Overview
    • 11.15.3 Renue By Science NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.15.4 Renue By Science NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Renue By Science Recent Developments
  • 11.16 NOW Foods
    • 11.16.1 NOW Foods Company Information
    • 11.16.2 NOW Foods Overview
    • 11.16.3 NOW Foods NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.16.4 NOW Foods NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.16.5 NOW Foods Recent Developments
  • 11.17 Tru Niagen (Chromadex)
    • 11.17.1 Tru Niagen (Chromadex) Company Information
    • 11.17.2 Tru Niagen (Chromadex) Overview
    • 11.17.3 Tru Niagen (Chromadex) NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.17.4 Tru Niagen (Chromadex) NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.17.5 Tru Niagen (Chromadex) Recent Developments
  • 11.18 Elysium Health
    • 11.18.1 Elysium Health Company Information
    • 11.18.2 Elysium Health Overview
    • 11.18.3 Elysium Health NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.18.4 Elysium Health NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.18.5 Elysium Health Recent Developments
  • 11.19 Tesseract Medical Research
    • 11.19.1 Tesseract Medical Research Company Information
    • 11.19.2 Tesseract Medical Research Overview
    • 11.19.3 Tesseract Medical Research NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.19.4 Tesseract Medical Research NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.19.5 Tesseract Medical Research Recent Developments
  • 11.20 Quicksilver Scientific
    • 11.20.1 Quicksilver Scientific Company Information
    • 11.20.2 Quicksilver Scientific Overview
    • 11.20.3 Quicksilver Scientific NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.20.4 Quicksilver Scientific NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.20.5 Quicksilver Scientific Recent Developments
  • 11.21 LifeVantage
    • 11.21.1 LifeVantage Company Information
    • 11.21.2 LifeVantage Overview
    • 11.21.3 LifeVantage NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.21.4 LifeVantage NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.21.5 LifeVantage Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 NAD+ Enhancer Industry Chain Analysis
  • 12.2 NAD+ Enhancer Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 NAD+ Enhancer Production Mode & Process
  • 12.4 NAD+ Enhancer Sales and Marketing
    • 12.4.1 NAD+ Enhancer Sales Channels
    • 12.4.2 NAD+ Enhancer Distributors
  • 12.5 NAD+ Enhancer Customers

13 Market Dynamics

  • 13.1 NAD+ Enhancer Industry Trends
  • 13.2 NAD+ Enhancer Market Drivers
  • 13.3 NAD+ Enhancer Market Challenges
  • 13.4 NAD+ Enhancer Market Restraints

14 Key Findings in The Global NAD+ Enhancer Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 NAD+ Enhancer Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global NAD+ Enhancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Capsules
    • 1.2.3 Arm Transdermal Patch
    • 1.2.4 Infusion Fluids
    • 1.2.5 Nasal Spray
    • 1.2.6 Sublingual Tablets
    • 1.2.7 Other
  • 1.3 Market by Application
    • 1.3.1 Global NAD+ Enhancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Research Institutes
    • 1.3.5 Other
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global NAD+ Enhancer Sales Estimates and Forecasts 2018-2029
  • 2.2 Global NAD+ Enhancer Revenue by Region
    • 2.2.1 Global NAD+ Enhancer Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global NAD+ Enhancer Revenue by Region (2018-2023)
    • 2.2.3 Global NAD+ Enhancer Revenue by Region (2024-2029)
    • 2.2.4 Global NAD+ Enhancer Revenue Market Share by Region (2018-2029)
  • 2.3 Global NAD+ Enhancer Sales Estimates and Forecasts 2018-2029
  • 2.4 Global NAD+ Enhancer Sales by Region
    • 2.4.1 Global NAD+ Enhancer Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global NAD+ Enhancer Sales by Region (2018-2023)
    • 2.4.3 Global NAD+ Enhancer Sales by Region (2024-2029)
    • 2.4.4 Global NAD+ Enhancer Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global NAD+ Enhancer Sales by Manufacturers
    • 3.1.1 Global NAD+ Enhancer Sales by Manufacturers (2018-2023)
    • 3.1.2 Global NAD+ Enhancer Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of NAD+ Enhancer in 2022
  • 3.2 Global NAD+ Enhancer Revenue by Manufacturers
    • 3.2.1 Global NAD+ Enhancer Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global NAD+ Enhancer Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by NAD+ Enhancer Revenue in 2022
  • 3.3 Global Key Players of NAD+ Enhancer, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global NAD+ Enhancer Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global NAD+ Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of NAD+ Enhancer, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of NAD+ Enhancer, Product Offered and Application
  • 3.8 Global Key Manufacturers of NAD+ Enhancer, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global NAD+ Enhancer Sales by Type
    • 4.1.1 Global NAD+ Enhancer Historical Sales by Type (2018-2023)
    • 4.1.2 Global NAD+ Enhancer Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • 4.2 Global NAD+ Enhancer Revenue by Type
    • 4.2.1 Global NAD+ Enhancer Historical Revenue by Type (2018-2023)
    • 4.2.2 Global NAD+ Enhancer Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • 4.3 Global NAD+ Enhancer Price by Type
    • 4.3.1 Global NAD+ Enhancer Price by Type (2018-2023)
    • 4.3.2 Global NAD+ Enhancer Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global NAD+ Enhancer Sales by Application
    • 5.1.1 Global NAD+ Enhancer Historical Sales by Application (2018-2023)
    • 5.1.2 Global NAD+ Enhancer Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • 5.2 Global NAD+ Enhancer Revenue by Application
    • 5.2.1 Global NAD+ Enhancer Historical Revenue by Application (2018-2023)
    • 5.2.2 Global NAD+ Enhancer Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • 5.3 Global NAD+ Enhancer Price by Application
    • 5.3.1 Global NAD+ Enhancer Price by Application (2018-2023)
    • 5.3.2 Global NAD+ Enhancer Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada NAD+ Enhancer Market Size by Type
    • 6.1.1 US & Canada NAD+ Enhancer Sales by Type (2018-2029)
    • 6.1.2 US & Canada NAD+ Enhancer Revenue by Type (2018-2029)
  • 6.2 US & Canada NAD+ Enhancer Market Size by Application
    • 6.2.1 US & Canada NAD+ Enhancer Sales by Application (2018-2029)
    • 6.2.2 US & Canada NAD+ Enhancer Revenue by Application (2018-2029)
  • 6.3 US & Canada NAD+ Enhancer Market Size by Country
    • 6.3.1 US & Canada NAD+ Enhancer Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada NAD+ Enhancer Sales by Country (2018-2029)
    • 6.3.3 US & Canada NAD+ Enhancer Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe NAD+ Enhancer Market Size by Type
    • 7.1.1 Europe NAD+ Enhancer Sales by Type (2018-2029)
    • 7.1.2 Europe NAD+ Enhancer Revenue by Type (2018-2029)
  • 7.2 Europe NAD+ Enhancer Market Size by Application
    • 7.2.1 Europe NAD+ Enhancer Sales by Application (2018-2029)
    • 7.2.2 Europe NAD+ Enhancer Revenue by Application (2018-2029)
  • 7.3 Europe NAD+ Enhancer Market Size by Country
    • 7.3.1 Europe NAD+ Enhancer Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe NAD+ Enhancer Sales by Country (2018-2029)
    • 7.3.3 Europe NAD+ Enhancer Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China NAD+ Enhancer Market Size
    • 8.1.1 China NAD+ Enhancer Sales (2018-2029)
    • 8.1.2 China NAD+ Enhancer Revenue (2018-2029)
  • 8.2 China NAD+ Enhancer Market Size by Application
    • 8.2.1 China NAD+ Enhancer Sales by Application (2018-2029)
    • 8.2.2 China NAD+ Enhancer Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia NAD+ Enhancer Market Size by Type
    • 9.1.1 Asia NAD+ Enhancer Sales by Type (2018-2029)
    • 9.1.2 Asia NAD+ Enhancer Revenue by Type (2018-2029)
  • 9.2 Asia NAD+ Enhancer Market Size by Application
    • 9.2.1 Asia NAD+ Enhancer Sales by Application (2018-2029)
    • 9.2.2 Asia NAD+ Enhancer Revenue by Application (2018-2029)
  • 9.3 Asia NAD+ Enhancer Sales by Region
    • 9.3.1 Asia NAD+ Enhancer Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia NAD+ Enhancer Revenue by Region (2018-2029)
    • 9.3.3 Asia NAD+ Enhancer Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America NAD+ Enhancer Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America NAD+ Enhancer Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America NAD+ Enhancer Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America NAD+ Enhancer Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America NAD+ Enhancer Sales by Country
    • 10.3.1 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America NAD+ Enhancer Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Chromadex
    • 11.1.1 Chromadex Company Information
    • 11.1.2 Chromadex Overview
    • 11.1.3 Chromadex NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Chromadex NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Chromadex Recent Developments
  • 11.2 Alive by Nature
    • 11.2.1 Alive by Nature Company Information
    • 11.2.2 Alive by Nature Overview
    • 11.2.3 Alive by Nature NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Alive by Nature NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Alive by Nature Recent Developments
  • 11.3 Life Extension
    • 11.3.1 Life Extension Company Information
    • 11.3.2 Life Extension Overview
    • 11.3.3 Life Extension NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Life Extension NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Life Extension Recent Developments
  • 11.4 Bulk Supplements
    • 11.4.1 Bulk Supplements Company Information
    • 11.4.2 Bulk Supplements Overview
    • 11.4.3 Bulk Supplements NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Bulk Supplements NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Bulk Supplements Recent Developments
  • 11.5 NMN Bio
    • 11.5.1 NMN Bio Company Information
    • 11.5.2 NMN Bio Overview
    • 11.5.3 NMN Bio NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 NMN Bio NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 NMN Bio Recent Developments
  • 11.6 Swanson Health
    • 11.6.1 Swanson Health Company Information
    • 11.6.2 Swanson Health Overview
    • 11.6.3 Swanson Health NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Swanson Health NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Swanson Health Recent Developments
  • 11.7 Pure Nootropics
    • 11.7.1 Pure Nootropics Company Information
    • 11.7.2 Pure Nootropics Overview
    • 11.7.3 Pure Nootropics NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Pure Nootropics NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Pure Nootropics Recent Developments
  • 11.8 Thrivous
    • 11.8.1 Thrivous Company Information
    • 11.8.2 Thrivous Overview
    • 11.8.3 Thrivous NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Thrivous NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Thrivous Recent Developments
  • 11.9 BioTech Life Sciences
    • 11.9.1 BioTech Life Sciences Company Information
    • 11.9.2 BioTech Life Sciences Overview
    • 11.9.3 BioTech Life Sciences NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 BioTech Life Sciences NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 BioTech Life Sciences Recent Developments
  • 11.10 Bioage
    • 11.10.1 Bioage Company Information
    • 11.10.2 Bioage Overview
    • 11.10.3 Bioage NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Bioage NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Bioage Recent Developments
  • 11.11 Alitura Naturals
    • 11.11.1 Alitura Naturals Company Information
    • 11.11.2 Alitura Naturals Overview
    • 11.11.3 Alitura Naturals NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 Alitura Naturals NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Alitura Naturals Recent Developments
  • 11.12 Genex Formulas
    • 11.12.1 Genex Formulas Company Information
    • 11.12.2 Genex Formulas Overview
    • 11.12.3 Genex Formulas NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 Genex Formulas NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Genex Formulas Recent Developments
  • 11.13 Prohealth
    • 11.13.1 Prohealth Company Information
    • 11.13.2 Prohealth Overview
    • 11.13.3 Prohealth NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.13.4 Prohealth NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Prohealth Recent Developments
  • 11.14 LifeSeasons
    • 11.14.1 LifeSeasons Company Information
    • 11.14.2 LifeSeasons Overview
    • 11.14.3 LifeSeasons NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.14.4 LifeSeasons NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 LifeSeasons Recent Developments
  • 11.15 Renue By Science
    • 11.15.1 Renue By Science Company Information
    • 11.15.2 Renue By Science Overview
    • 11.15.3 Renue By Science NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.15.4 Renue By Science NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Renue By Science Recent Developments
  • 11.16 NOW Foods
    • 11.16.1 NOW Foods Company Information
    • 11.16.2 NOW Foods Overview
    • 11.16.3 NOW Foods NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.16.4 NOW Foods NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.16.5 NOW Foods Recent Developments
  • 11.17 Tru Niagen (Chromadex)
    • 11.17.1 Tru Niagen (Chromadex) Company Information
    • 11.17.2 Tru Niagen (Chromadex) Overview
    • 11.17.3 Tru Niagen (Chromadex) NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.17.4 Tru Niagen (Chromadex) NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.17.5 Tru Niagen (Chromadex) Recent Developments
  • 11.18 Elysium Health
    • 11.18.1 Elysium Health Company Information
    • 11.18.2 Elysium Health Overview
    • 11.18.3 Elysium Health NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.18.4 Elysium Health NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.18.5 Elysium Health Recent Developments
  • 11.19 Tesseract Medical Research
    • 11.19.1 Tesseract Medical Research Company Information
    • 11.19.2 Tesseract Medical Research Overview
    • 11.19.3 Tesseract Medical Research NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.19.4 Tesseract Medical Research NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.19.5 Tesseract Medical Research Recent Developments
  • 11.20 Quicksilver Scientific
    • 11.20.1 Quicksilver Scientific Company Information
    • 11.20.2 Quicksilver Scientific Overview
    • 11.20.3 Quicksilver Scientific NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.20.4 Quicksilver Scientific NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.20.5 Quicksilver Scientific Recent Developments
  • 11.21 LifeVantage
    • 11.21.1 LifeVantage Company Information
    • 11.21.2 LifeVantage Overview
    • 11.21.3 LifeVantage NAD+ Enhancer Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.21.4 LifeVantage NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.21.5 LifeVantage Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 NAD+ Enhancer Industry Chain Analysis
  • 12.2 NAD+ Enhancer Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 NAD+ Enhancer Production Mode & Process
  • 12.4 NAD+ Enhancer Sales and Marketing
    • 12.4.1 NAD+ Enhancer Sales Channels
    • 12.4.2 NAD+ Enhancer Distributors
  • 12.5 NAD+ Enhancer Customers

13 Market Dynamics

  • 13.1 NAD+ Enhancer Industry Trends
  • 13.2 NAD+ Enhancer Market Drivers
  • 13.3 NAD+ Enhancer Market Challenges
  • 13.4 NAD+ Enhancer Market Restraints

14 Key Findings in The Global NAD+ Enhancer Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer

List of Tables

  • Table 1. Global NAD+ Enhancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Capsules
  • Table 3. Major Manufacturers of Arm Transdermal Patch
  • Table 4. Major Manufacturers of Infusion Fluids
  • Table 5. Major Manufacturers of Nasal Spray
  • Table 6. Major Manufacturers of Sublingual Tablets
  • Table 7. Major Manufacturers of Other
  • Table 8. Global NAD+ Enhancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 9. Global NAD+ Enhancer Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 10. Global NAD+ Enhancer Revenue by Region (2018-2023) & (US$ Million)
  • Table 11. Global NAD+ Enhancer Revenue by Region (2024-2029) & (US$ Million)
  • Table 12. Global NAD+ Enhancer Revenue Market Share by Region (2018-2023)
  • Table 13. Global NAD+ Enhancer Revenue Market Share by Region (2024-2029)
  • Table 14. Global NAD+ Enhancer Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 15. Global NAD+ Enhancer Sales by Region (2018-2023) & (K Units)
  • Table 16. Global NAD+ Enhancer Sales by Region (2024-2029) & (K Units)
  • Table 17. Global NAD+ Enhancer Sales Market Share by Region (2018-2023)
  • Table 18. Global NAD+ Enhancer Sales Market Share by Region (2024-2029)
  • Table 19. Global NAD+ Enhancer Sales by Manufacturers (2018-2023) & (K Units)
  • Table 20. Global NAD+ Enhancer Sales Share by Manufacturers (2018-2023)
  • Table 21. Global NAD+ Enhancer Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 22. Global NAD+ Enhancer Revenue Share by Manufacturers (2018-2023)
  • Table 23. Global Key Players of NAD+ Enhancer, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 24. NAD+ Enhancer Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 25. Global NAD+ Enhancer Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 26. Global NAD+ Enhancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Enhancer as of 2022)
  • Table 27. Global Key Manufacturers of NAD+ Enhancer, Manufacturing Base Distribution and Headquarters
  • Table 28. Global Key Manufacturers of NAD+ Enhancer, Product Offered and Application
  • Table 29. Global Key Manufacturers of NAD+ Enhancer, Date of Enter into This Industry
  • Table 30. Mergers & Acquisitions, Expansion Plans
  • Table 31. Global NAD+ Enhancer Sales by Type (2018-2023) & (K Units)
  • Table 32. Global NAD+ Enhancer Sales by Type (2024-2029) & (K Units)
  • Table 33. Global NAD+ Enhancer Sales Share by Type (2018-2023)
  • Table 34. Global NAD+ Enhancer Sales Share by Type (2024-2029)
  • Table 35. Global NAD+ Enhancer Revenue by Type (2018-2023) & (US$ Million)
  • Table 36. Global NAD+ Enhancer Revenue by Type (2024-2029) & (US$ Million)
  • Table 37. Global NAD+ Enhancer Revenue Share by Type (2018-2023)
  • Table 38. Global NAD+ Enhancer Revenue Share by Type (2024-2029)
  • Table 39. NAD+ Enhancer Price by Type (2018-2023) & (US$/Unit)
  • Table 40. Global NAD+ Enhancer Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 41. Global NAD+ Enhancer Sales by Application (2018-2023) & (K Units)
  • Table 42. Global NAD+ Enhancer Sales by Application (2024-2029) & (K Units)
  • Table 43. Global NAD+ Enhancer Sales Share by Application (2018-2023)
  • Table 44. Global NAD+ Enhancer Sales Share by Application (2024-2029)
  • Table 45. Global NAD+ Enhancer Revenue by Application (2018-2023) & (US$ Million)
  • Table 46. Global NAD+ Enhancer Revenue by Application (2024-2029) & (US$ Million)
  • Table 47. Global NAD+ Enhancer Revenue Share by Application (2018-2023)
  • Table 48. Global NAD+ Enhancer Revenue Share by Application (2024-2029)
  • Table 49. NAD+ Enhancer Price by Application (2018-2023) & (US$/Unit)
  • Table 50. Global NAD+ Enhancer Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 51. US & Canada NAD+ Enhancer Sales by Type (2018-2023) & (K Units)
  • Table 52. US & Canada NAD+ Enhancer Sales by Type (2024-2029) & (K Units)
  • Table 53. US & Canada NAD+ Enhancer Revenue by Type (2018-2023) & (US$ Million)
  • Table 54. US & Canada NAD+ Enhancer Revenue by Type (2024-2029) & (US$ Million)
  • Table 55. US & Canada NAD+ Enhancer Sales by Application (2018-2023) & (K Units)
  • Table 56. US & Canada NAD+ Enhancer Sales by Application (2024-2029) & (K Units)
  • Table 57. US & Canada NAD+ Enhancer Revenue by Application (2018-2023) & (US$ Million)
  • Table 58. US & Canada NAD+ Enhancer Revenue by Application (2024-2029) & (US$ Million)
  • Table 59. US & Canada NAD+ Enhancer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 60. US & Canada NAD+ Enhancer Revenue by Country (2018-2023) & (US$ Million)
  • Table 61. US & Canada NAD+ Enhancer Revenue by Country (2024-2029) & (US$ Million)
  • Table 62. US & Canada NAD+ Enhancer Sales by Country (2018-2023) & (K Units)
  • Table 63. US & Canada NAD+ Enhancer Sales by Country (2024-2029) & (K Units)
  • Table 64. Europe NAD+ Enhancer Sales by Type (2018-2023) & (K Units)
  • Table 65. Europe NAD+ Enhancer Sales by Type (2024-2029) & (K Units)
  • Table 66. Europe NAD+ Enhancer Revenue by Type (2018-2023) & (US$ Million)
  • Table 67. Europe NAD+ Enhancer Revenue by Type (2024-2029) & (US$ Million)
  • Table 68. Europe NAD+ Enhancer Sales by Application (2018-2023) & (K Units)
  • Table 69. Europe NAD+ Enhancer Sales by Application (2024-2029) & (K Units)
  • Table 70. Europe NAD+ Enhancer Revenue by Application (2018-2023) & (US$ Million)
  • Table 71. Europe NAD+ Enhancer Revenue by Application (2024-2029) & (US$ Million)
  • Table 72. Europe NAD+ Enhancer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 73. Europe NAD+ Enhancer Revenue by Country (2018-2023) & (US$ Million)
  • Table 74. Europe NAD+ Enhancer Revenue by Country (2024-2029) & (US$ Million)
  • Table 75. Europe NAD+ Enhancer Sales by Country (2018-2023) & (K Units)
  • Table 76. Europe NAD+ Enhancer Sales by Country (2024-2029) & (K Units)
  • Table 77. China NAD+ Enhancer Sales by Type (2018-2023) & (K Units)
  • Table 78. China NAD+ Enhancer Sales by Type (2024-2029) & (K Units)
  • Table 79. China NAD+ Enhancer Revenue by Type (2018-2023) & (US$ Million)
  • Table 80. China NAD+ Enhancer Revenue by Type (2024-2029) & (US$ Million)
  • Table 81. China NAD+ Enhancer Sales by Application (2018-2023) & (K Units)
  • Table 82. China NAD+ Enhancer Sales by Application (2024-2029) & (K Units)
  • Table 83. China NAD+ Enhancer Revenue by Application (2018-2023) & (US$ Million)
  • Table 84. China NAD+ Enhancer Revenue by Application (2024-2029) & (US$ Million)
  • Table 85. Asia NAD+ Enhancer Sales by Type (2018-2023) & (K Units)
  • Table 86. Asia NAD+ Enhancer Sales by Type (2024-2029) & (K Units)
  • Table 87. Asia NAD+ Enhancer Revenue by Type (2018-2023) & (US$ Million)
  • Table 88. Asia NAD+ Enhancer Revenue by Type (2024-2029) & (US$ Million)
  • Table 89. Asia NAD+ Enhancer Sales by Application (2018-2023) & (K Units)
  • Table 90. Asia NAD+ Enhancer Sales by Application (2024-2029) & (K Units)
  • Table 91. Asia NAD+ Enhancer Revenue by Application (2018-2023) & (US$ Million)
  • Table 92. Asia NAD+ Enhancer Revenue by Application (2024-2029) & (US$ Million)
  • Table 93. Asia NAD+ Enhancer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 94. Asia NAD+ Enhancer Revenue by Region (2018-2023) & (US$ Million)
  • Table 95. Asia NAD+ Enhancer Revenue by Region (2024-2029) & (US$ Million)
  • Table 96. Asia NAD+ Enhancer Sales by Region (2018-2023) & (K Units)
  • Table 97. Asia NAD+ Enhancer Sales by Region (2024-2029) & (K Units)
  • Table 98. Middle East, Africa and Latin America NAD+ Enhancer Sales by Type (2018-2023) & (K Units)
  • Table 99. Middle East, Africa and Latin America NAD+ Enhancer Sales by Type (2024-2029) & (K Units)
  • Table 100. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Type (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Type (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America NAD+ Enhancer Sales by Application (2018-2023) & (K Units)
  • Table 103. Middle East, Africa and Latin America NAD+ Enhancer Sales by Application (2024-2029) & (K Units)
  • Table 104. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Application (2018-2023) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Application (2024-2029) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America NAD+ Enhancer Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 107. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country (2018-2023) & (US$ Million)
  • Table 108. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country (2024-2029) & (US$ Million)
  • Table 109. Middle East, Africa and Latin America NAD+ Enhancer Sales by Country (2018-2023) & (K Units)
  • Table 110. Middle East, Africa and Latin America NAD+ Enhancer Sales by Country (2024-2029) & (K Units)
  • Table 111. Chromadex Company Information
  • Table 112. Chromadex Description and Major Businesses
  • Table 113. Chromadex NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 114. Chromadex NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. Chromadex Recent Developments
  • Table 116. Alive by Nature Company Information
  • Table 117. Alive by Nature Description and Major Businesses
  • Table 118. Alive by Nature NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 119. Alive by Nature NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Alive by Nature Recent Developments
  • Table 121. Life Extension Company Information
  • Table 122. Life Extension Description and Major Businesses
  • Table 123. Life Extension NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 124. Life Extension NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. Life Extension Recent Developments
  • Table 126. Bulk Supplements Company Information
  • Table 127. Bulk Supplements Description and Major Businesses
  • Table 128. Bulk Supplements NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 129. Bulk Supplements NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Bulk Supplements Recent Developments
  • Table 131. NMN Bio Company Information
  • Table 132. NMN Bio Description and Major Businesses
  • Table 133. NMN Bio NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 134. NMN Bio NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. NMN Bio Recent Developments
  • Table 136. Swanson Health Company Information
  • Table 137. Swanson Health Description and Major Businesses
  • Table 138. Swanson Health NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 139. Swanson Health NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Swanson Health Recent Developments
  • Table 141. Pure Nootropics Company Information
  • Table 142. Pure Nootropics Description and Major Businesses
  • Table 143. Pure Nootropics NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 144. Pure Nootropics NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. Pure Nootropics Recent Developments
  • Table 146. Thrivous Company Information
  • Table 147. Thrivous Description and Major Businesses
  • Table 148. Thrivous NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 149. Thrivous NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. Thrivous Recent Developments
  • Table 151. BioTech Life Sciences Company Information
  • Table 152. BioTech Life Sciences Description and Major Businesses
  • Table 153. BioTech Life Sciences NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 154. BioTech Life Sciences NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 155. BioTech Life Sciences Recent Developments
  • Table 156. Bioage Company Information
  • Table 157. Bioage Description and Major Businesses
  • Table 158. Bioage NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 159. Bioage NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 160. Bioage Recent Developments
  • Table 161. Alitura Naturals Company Information
  • Table 162. Alitura Naturals Description and Major Businesses
  • Table 163. Alitura Naturals NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 164. Alitura Naturals NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 165. Alitura Naturals Recent Developments
  • Table 166. Genex Formulas Company Information
  • Table 167. Genex Formulas Description and Major Businesses
  • Table 168. Genex Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 169. Genex Formulas NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 170. Genex Formulas Recent Developments
  • Table 171. Prohealth Company Information
  • Table 172. Prohealth Description and Major Businesses
  • Table 173. Prohealth NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 174. Prohealth NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 175. Prohealth Recent Developments
  • Table 176. LifeSeasons Company Information
  • Table 177. LifeSeasons Description and Major Businesses
  • Table 178. LifeSeasons NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 179. LifeSeasons NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 180. LifeSeasons Recent Developments
  • Table 181. Renue By Science Company Information
  • Table 182. Renue By Science Description and Major Businesses
  • Table 183. Renue By Science NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 184. Renue By Science NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 185. Renue By Science Recent Developments
  • Table 186. NOW Foods Company Information
  • Table 187. NOW Foods Description and Major Businesses
  • Table 188. NOW Foods NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 189. NOW Foods NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 190. NOW Foods Recent Developments
  • Table 191. Tru Niagen (Chromadex) Company Information
  • Table 192. Tru Niagen (Chromadex) Description and Major Businesses
  • Table 193. Tru Niagen (Chromadex) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 194. Tru Niagen (Chromadex) NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 195. Tru Niagen (Chromadex) Recent Developments
  • Table 196. Elysium Health Company Information
  • Table 197. Elysium Health Description and Major Businesses
  • Table 198. Elysium Health NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 199. Elysium Health NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 200. Elysium Health Recent Developments
  • Table 201. Tesseract Medical Research Company Information
  • Table 202. Tesseract Medical Research Description and Major Businesses
  • Table 203. Tesseract Medical Research NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 204. Tesseract Medical Research NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 205. Tesseract Medical Research Recent Developments
  • Table 206. Quicksilver Scientific Company Information
  • Table 207. Quicksilver Scientific Description and Major Businesses
  • Table 208. Quicksilver Scientific NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 209. Quicksilver Scientific NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 210. Quicksilver Scientific Recent Developments
  • Table 211. LifeVantage Company Information
  • Table 212. LifeVantage Description and Major Businesses
  • Table 213. LifeVantage NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 214. LifeVantage NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 215. LifeVantage Recent Developments
  • Table 216. Key Raw Materials Lists
  • Table 217. Raw Materials Key Suppliers Lists
  • Table 218. NAD+ Enhancer Distributors List
  • Table 219. NAD+ Enhancer Customers List
  • Table 220. NAD+ Enhancer Market Trends
  • Table 221. NAD+ Enhancer Market Drivers
  • Table 222. NAD+ Enhancer Market Challenges
  • Table 223. NAD+ Enhancer Market Restraints
  • Table 224. Research Programs/Design for This Report
  • Table 225. Key Data Information from Secondary Sources
  • Table 226. Key Data Information from Primary Sources

List of Figures

  • Figure 1. NAD+ Enhancer Product Picture
  • Figure 2. Global NAD+ Enhancer Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global NAD+ Enhancer Market Share by Type in 2022 & 2029
  • Figure 4. Capsules Product Picture
  • Figure 5. Arm Transdermal Patch Product Picture
  • Figure 6. Infusion Fluids Product Picture
  • Figure 7. Nasal Spray Product Picture
  • Figure 8. Sublingual Tablets Product Picture
  • Figure 9. Other Product Picture
  • Figure 10. Global NAD+ Enhancer Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 11. Global NAD+ Enhancer Market Share by Application in 2022 & 2029
  • Figure 12. Hospitals
  • Figure 13. Clinics
  • Figure 14. Research Institutes
  • Figure 15. Other
  • Figure 16. NAD+ Enhancer Report Years Considered
  • Figure 17. Global NAD+ Enhancer Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 18. Global NAD+ Enhancer Revenue 2018-2029 (US$ Million)
  • Figure 19. Global NAD+ Enhancer Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 20. Global NAD+ Enhancer Revenue Market Share by Region (2018-2029)
  • Figure 21. Global NAD+ Enhancer Sales 2018-2029 ((K Units)
  • Figure 22. Global NAD+ Enhancer Sales Market Share by Region (2018-2029)
  • Figure 23. US & Canada NAD+ Enhancer Sales YoY (2018-2029) & (K Units)
  • Figure 24. US & Canada NAD+ Enhancer Revenue YoY (2018-2029) & (US$ Million)
  • Figure 25. Europe NAD+ Enhancer Sales YoY (2018-2029) & (K Units)
  • Figure 26. Europe NAD+ Enhancer Revenue YoY (2018-2029) & (US$ Million)
  • Figure 27. China NAD+ Enhancer Sales YoY (2018-2029) & (K Units)
  • Figure 28. China NAD+ Enhancer Revenue YoY (2018-2029) & (US$ Million)
  • Figure 29. Asia (excluding China) NAD+ Enhancer Sales YoY (2018-2029) & (K Units)
  • Figure 30. Asia (excluding China) NAD+ Enhancer Revenue YoY (2018-2029) & (US$ Million)
  • Figure 31. Middle East, Africa and Latin America NAD+ Enhancer Sales YoY (2018-2029) & (K Units)
  • Figure 32. Middle East, Africa and Latin America NAD+ Enhancer Revenue YoY (2018-2029) & (US$ Million)
  • Figure 33. The NAD+ Enhancer Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 34. The Top 5 and 10 Largest Manufacturers of NAD+ Enhancer in the World: Market Share by NAD+ Enhancer Revenue in 2022
  • Figure 35. Global NAD+ Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 36. Global NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • Figure 37. Global NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • Figure 38. Global NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • Figure 39. Global NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • Figure 40. US & Canada NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • Figure 41. US & Canada NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • Figure 42. US & Canada NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • Figure 43. US & Canada NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • Figure 44. US & Canada NAD+ Enhancer Revenue Share by Country (2018-2029)
  • Figure 45. US & Canada NAD+ Enhancer Sales Share by Country (2018-2029)
  • Figure 46. U.S. NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 47. Canada NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 48. Europe NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • Figure 49. Europe NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • Figure 50. Europe NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • Figure 51. Europe NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • Figure 52. Europe NAD+ Enhancer Revenue Share by Country (2018-2029)
  • Figure 53. Europe NAD+ Enhancer Sales Share by Country (2018-2029)
  • Figure 54. Germany NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 55. France NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 56. U.K. NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 57. Italy NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 58. Russia NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 59. China NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • Figure 60. China NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • Figure 61. China NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • Figure 62. China NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • Figure 63. Asia NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • Figure 64. Asia NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • Figure 65. Asia NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • Figure 66. Asia NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • Figure 67. Asia NAD+ Enhancer Revenue Share by Region (2018-2029)
  • Figure 68. Asia NAD+ Enhancer Sales Share by Region (2018-2029)
  • Figure 69. Japan NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 70. South Korea NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 71. China Taiwan NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 72. Southeast Asia NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 73. India NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 74. Middle East, Africa and Latin America NAD+ Enhancer Sales Market Share by Type (2018-2029)
  • Figure 75. Middle East, Africa and Latin America NAD+ Enhancer Revenue Market Share by Type (2018-2029)
  • Figure 76. Middle East, Africa and Latin America NAD+ Enhancer Sales Market Share by Application (2018-2029)
  • Figure 77. Middle East, Africa and Latin America NAD+ Enhancer Revenue Market Share by Application (2018-2029)
  • Figure 78. Middle East, Africa and Latin America NAD+ Enhancer Revenue Share by Country (2018-2029)
  • Figure 79. Middle East, Africa and Latin America NAD+ Enhancer Sales Share by Country (2018-2029)
  • Figure 80. Brazil NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 81. Mexico NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 82. Turkey NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 83. Israel NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 84. GCC Countries NAD+ Enhancer Revenue (2018-2029) & (US$ Million)
  • Figure 85. NAD+ Enhancer Value Chain
  • Figure 86. NAD+ Enhancer Production Process
  • Figure 87. Channels of Distribution
  • Figure 88. Distributors Profiles
  • Figure 89. Bottom-up and Top-down Approaches for This Report
  • Figure 90. Data Triangulation
  • Figure 91. Key Executives Interviewed
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!